Poly(ADP-ribose) polymerase in DNA damage-response pathway: Implications for radiation oncology

被引:0
|
作者
Soldatenkov, VA
Smulson, M
机构
[1] Georgetown Univ, Sch Med, Dept Radiat Med, Div Radiat Res, Washington, DC 20007 USA
[2] Georgetown Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC USA
关键词
poly(ADP-ribose) polymerase; ionizing radiation; DNA damage repair; cell death; gene regulation;
D O I
10.1002/(SICI)1097-0215(20000420)90:2<59::AID-IJC1>3.0.CO;2-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Poly(ADP-ribose) polymerase (PARP) catalyzes the transfer of successive units of ADP-ribose moiety from NAD(+) covalently to itself and other nuclear acceptor proteins. PARP is a zinc finger-containing protein, allowing the enzyme to bind to either double- or single-strand DNA breaks without any apparent sequence preference. The catalytic activity of PARP is strictly dependent on the presence of strand breaks in DNA and is modulated by the level of automodification, Data from many studies show that PARP is involved in numerous biological functions, all of which are associated with the breaking and rejoining of DNA strands, and plays a pivotal role in DNA damage repair. Recent advances in apoptosis research identified PARP as one of the intracellular "death substrates" and demonstrated the involvement of polymerase in the execution of programmed cell death. This review summarizes the biological effects of PARP function that may have a potential for targeted sensitization of tumor cells to genotoxic agents and radiotherapy. Int. J. Cancer (Radiat. Oncol. Invest.) 90, 59-67 (2000). (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:59 / 67
页数:9
相关论文
共 50 条
  • [31] Poly(ADP-ribose) polymerase activation in the reperfused myocardium
    Szabó, G
    Liaudet, L
    Hagl, S
    Szabó, C
    CARDIOVASCULAR RESEARCH, 2004, 61 (03) : 471 - 480
  • [32] Poly (ADP-ribose) Polymerase Inhibitors in Cancer Treatment
    Mason, Kathryn A.
    Raju, Uma
    Buchholz, Thomas A.
    Wang, Li
    Milas, Zvonimir L.
    Milas, Luka
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (01): : 90 - 100
  • [33] Poly(ADP-ribose)polymerase inhibition - Where now?
    Woon, ECY
    Threadgill, MD
    CURRENT MEDICINAL CHEMISTRY, 2005, 12 (20) : 2373 - 2392
  • [34] EXPRESSION OF POLY(ADP-RIBOSE) POLYMERASE IN BONE REGENERATION
    Lo Muzio, L.
    Pannone, G.
    Santarelli, A.
    Lo Russo, L.
    De Lillo, A.
    Rubini, C.
    Bambini, F.
    Bufo, P.
    Dioguardi, M.
    Procaccini, M.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2014, 28 (04) : 801 - 807
  • [35] Poly(ADP-ribose) polymerase activity and inhibition in cancer
    Dulaney, Caleb
    Marcrom, Samuel
    Stanley, Jennifer
    Yang, Eddy S.
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2017, 63 : 144 - 153
  • [36] Effects of poly(ADP-ribose) polymerase inhibition in bladder damage caused by cyclophosphamide in rats
    Korkmaz, Ahmet
    Kurt, Buelent
    Yildirim, Ibrahim
    Basal, Seref
    Topal, Turgut
    Sadir, Serdar
    Oeter, Suekrue
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2008, 233 (03) : 338 - 343
  • [37] Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors
    Tentori, L
    Portarena, I
    Graziani, G
    PHARMACOLOGICAL RESEARCH, 2002, 45 (02) : 73 - 85
  • [38] Mechanisms of poly (ADP-ribose) polymerase-1 and poly (ADP-ribose) glycohydrolase-mediated ischemic neuronal death
    Ying, W
    Alano, CC
    Cheng, Y
    Garnier, P
    Sevigny, MB
    Swanson, RA
    JOURNAL OF NEUROCHEMISTRY, 2003, 87 : 12 - 12
  • [39] POLY(ADP-RIBOSE)POLYMERASE - A PERPLEXING PARTICIPANT IN CELLULAR-RESPONSES TO DNA BREAKAGE
    CLEAVER, JE
    MORGAN, WF
    MUTATION RESEARCH, 1991, 257 (01): : 1 - 18
  • [40] Putting poly (ADP-ribose) polymerase and other DNA repair inhibitors into clinical practice
    Helleday, Thomas
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (06) : 609 - 614